Upon sequencing and transfer of TCRs from selected T-cell clones, Jchain-specific TCR-transduced CD8 T cells demonstrated potent killing of MM in vitro as well as in vivo, while no off-target effects were observed. This evidence concerns the gene CD8A and Miyoshi myopathy.